M.Pharm. or M.S (Pharm) (Medicinal Chemistry or Process Chemistry) GPAT Qualified. Development of Peripherally Restricted RAGE Inhibitors as Safe Therapeutics for Diabetic Peripheral Neuropathy.
Regional Centre for Biotechnology (RCB) is an Institution of National Importance established through an Act of Indian Parliament by the Department of Biotechnology, Govt. of India under the auspices of UNESCO. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology.
First class in M.Pharm / M.S. (Pharm.)/M.Tech (Pharm) / M.Tech in Medicinal Chemistry / Pharmaceutical Chemistry / Process Chemistry or Natural Product Chemistry / Pharmacology / Biotechnology with GATE / GPAT / CSIR-NET
Undergraduates or 4-year undergraduates in any branch of engineering from the non-biological sciences (BTech/BE) or pharmacy. Cancer Biology, Infectious Disease Biology, Plant Biotechnology and Interdisciplinary Sciences. Institute of Life Sciences
The candidates should possess (M.Pharm / M.S.(Pharm.) /M.Sc.) in Medicinal Chemistry / Pharmaceutical Chemistry / Pharmaceutical Sciences / Chemistry) or a PG degree in other relevant branch of Chemical Sciences.
Master of Pharmacy in Pharmaceutics with First Division and GPAT Qualified. Prior experience in handling machines like Spray Dryer, Texture Analyzer, Rheometer and HPLC.
First-class in M.Pharm with valid GPAT qualified candidates preferred. Candidates with good knowledge in in-vivo and in-vitro pharmacology, neuroscience, neuropharmacology, molecular biology will be preferred.